|Wednesday, May 8, 2013|
|01:00 AM ET|
We are proud to sponsor the National Brain Tumor Society's Advancing Research to Treatments for Brain Tumors Conference.
Biopharma executives and venture capital investors will share their criteria for investment and licensing of academic research, and researchers funded by the National Brain Tumor Society will present brain tumor drug candidates ready for early-stage investment and/or licensing.
Wednesday, May 8, 2013
9:30 am–5 pm
1111 Pennsylvania Ave., NW
Washington, DC 20004
Conference Center, Room 211
This conference is free to attend.
Registration for admission will be on a first-come, first-served basis.